Longitudinal cystic fibrosis care

Area of Science:

• Pulmonology and Genetics
• Biomedical Research

Background:

• Cystic fibrosis (CF) is a complex genetic disorder with significant lifelong health challenges.
• Current management focuses on multisystem interventions to address lung and gastrointestinal manifestations and comorbidities.
• Longitudinal care from birth through adulthood aims to relieve symptoms and enhance life expectancy.

Purpose of the Study:

• To review current and emerging strategies in cystic fibrosis care.
• To highlight the impact of understanding the cystic fibrosis transmembrane conductance regulator (CFTR) on treatment development.
• To discuss the potential of personalized medicine, including gene therapy and mutation-specific drugs.

Main Methods:

• Literature review of medical and surgical interventions for cystic fibrosis.
• Analysis of advancements in understanding CFTR molecular behavior.
• Exploration of novel therapeutic approaches targeting the root cause of CF.

Main Results:

• Multisystem interventions are crucial for managing CF manifestations and comorbidities.
• Increased knowledge of CFTR function has paved the way for targeted therapies.
• Personalized solutions, including gene and mutation-specific therapies, are transforming CF management.

Conclusions:

• Comprehensive care for cystic fibrosis requires a longitudinal, multisystem approach.
• Targeting CFTR offers promising avenues for disease modification and improved outcomes.
• Emerging paradigms in personalized medicine are set to revolutionize cystic fibrosis treatment.